Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/27/2026 | Q4 | $2.4B | -- | -- | $106.21 | -- |
| 10/22/2025 | Q3 | $2.4B | $2.6B | $112.33 | $109.36 | $2.97 |
| 07/23/2025 | Q2 | $2.5B | $2.6B | $108.54 | $106.20 | $2.33 |
| 04/22/2025 | Q1 | $2.3B | $2.3B | $94.83 | $106.07 | -$11.24 |
| 01/28/2025 | Q4 | $2.8B | $2.8B | $139.93 | $129.35 | $10.58 |
| 10/22/2024 | Q3 | $2.7B | $2.7B | $130.50 | $131.00 | -$0.50 |
| 07/23/2024 | Q2 | $2.5B | $2.6B | $120.69 | $121.21 | -$0.52 |
| 04/23/2024 | Q1 | $2.2B | $2.3B | $116.41 | $103.97 | $12.44 |
| 01/30/2024 | Q4 | $2.6B | $2.4B | $121.58 | $121.50 | $0.07 |
| 10/24/2023 | Q3 | $2.6B | $2.6B | $125.26 | $115.60 | $9.66 |
| 07/25/2023 | Q2 | -- | $2.3B | $116.54 | -- | -- |
| 04/25/2023 | Q1 | -- | $2.1B | $99.89 | -- | -- |
| 01/31/2023 | Q4 | -- | $2.6B | $133.44 | -- | -- |
| 10/25/2022 | Q3 | -- | $2.8B | $118.51 | -- | -- |
| 07/26/2022 | Q2 | -- | $2.6B | $123.65 | -- | -- |
| 04/26/2022 | Q1 | -- | $2.3B | $116.56 | -- | -- |
| 02/01/2022 | Q4 | -- | $2.2B | $89.10 | -- | -- |
| 10/21/2021 | Q3 | -- | $2.4B | $86.43 | -- | -- |
| 07/21/2021 | Q2 | -- | $2.2B | $82.45 | -- | -- |
| 05/04/2021 | Q1 | -- | $2B | $63.22 | -- | -- |
| 01/28/2021 | Q4 | -- | $2.3B | $76.92 | -- | -- |
| 10/20/2020 | Q3 | -- | $1.9B | $65.11 | -- | -- |
| 07/22/2020 | Q2 | -- | $1.6B | $42.50 | -- | -- |
| 04/23/2020 | Q1 | -- | $1.6B | $44.96 | -- | -- |
| 01/28/2020 | Q4 | -- | $2B | $64.40 | -- | -- |
| 10/18/2019 | Q3 | -- | $1.9B | $56.12 | -- | -- |
| 07/19/2019 | Q2 | -- | $1.8B | $53.10 | -- | -- |
| 04/22/2019 | Q1 | -- | $1.6B | $47.64 | -- | -- |
| 01/25/2019 | Q4 | -- | $2B | $58.57 | -- | -- |
| 10/18/2018 | Q3 | -- | $1.8B | $48.28 | -- | -- |
| 07/20/2018 | Q2 | -- | $1.8B | $49.05 | -- | -- |
| 04/19/2018 | Q1 | -- | $1.5B | $39.35 | -- | -- |
| 01/25/2018 | Q4 | -- | $1.8B | $28.88 | -- | -- |
| 10/19/2017 | Q3 | -- | $1.6B | $38.03 | -- | -- |
| 07/21/2017 | Q2 | -- | $1.5B | $35.19 | -- | -- |
| 04/20/2017 | Q1 | -- | $1.3B | $25.12 | -- | -- |
| 01/25/2017 | Q4 | -- | $1.7B | $37.80 | -- | -- |
| 10/20/2016 | Q3 | -- | $1.5B | $28.46 | -- | -- |
| 07/21/2016 | Q2 | -- | $1.4B | $22.01 | -- | -- |
| 04/21/2016 | Q1 | -- | $1.1B | $15.79 | -- | -- |
| 01/26/2016 | Q4 | -- | $1.5B | $31.92 | -- | -- |
NVR, Inc. reported $2.6B worth of top line sales in its most recent quarter.
NVR, Inc. announced earnings per share of $112.33 which represents a beat of analyst forecast a $109.36 per share.
NVR, Inc. reported $550.4M that represents $180.41 per share over the last quarter.
NVR, Inc.'s earnings are forecast to decrease from $506.69 per share to $492.81 per share next year representing a decrease of -16.9%.
NVR, Inc.'s next earnings date is January 27, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.